Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 2
1990 5
1991 6
1992 5
1993 1
1994 1
1995 6
1996 10
1997 9
1998 9
1999 13
2000 10
2001 9
2002 6
2003 14
2004 15
2005 7
2006 9
2007 6
2008 6
2009 1
2010 6
2011 3
2012 3
2013 2
2014 4
2015 2
2016 2
2017 4
2018 2
2019 2
2020 1
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

176 results
Results by year
Filters applied: . Clear all
Page 1
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia.
Kreitman RJ, Dearden C, Zinzani PL, Delgado J, Karlin L, Robak T, Gladstone DE, le Coutre P, Dietrich S, Gotic M, Larratt L, Offner F, Schiller G, Swords R, Bacon L, Bocchia M, Bouabdallah K, Breems DA, Cortelezzi A, Dinner S, Doubek M, Gjertsen BT, Gobbi M, Hellmann A, Lepretre S, Maloisel F, Ravandi F, Rousselot P, Rummel M, Siddiqi T, Tadmor T, Troussard X, Yi CA, Saglio G, Roboz GJ, Balic K, Standifer N, He P, Marshall S, Wilson W, Pastan I, Yao NS, Giles F. Kreitman RJ, et al. Among authors: maloisel f. Leukemia. 2018 Aug;32(8):1768-1777. doi: 10.1038/s41375-018-0210-1. Epub 2018 Jul 20. Leukemia. 2018. PMID: 30030507 Free PMC article.
Vitamin B12 (cobalamin) deficiency in elderly patients.
Andrès E, Loukili NH, Noel E, Kaltenbach G, Abdelgheni MB, Perrin AE, Noblet-Dick M, Maloisel F, Schlienger JL, Blicklé JF. Andrès E, et al. Among authors: maloisel f. CMAJ. 2004 Aug 3;171(3):251-9. doi: 10.1503/cmaj.1031155. CMAJ. 2004. PMID: 15289425 Free PMC article. Review.
Bortezomib plus dexamethasone is superior to vincristine plus doxorubicin plus dexamethasone as induction treatment prior to autologous stem-cell transplantation in newly diagnosed multiple myeloma: results of the IFM 2005-01 phase III trial.
Harousseau JL, Attal M, Avet-Loiseau H, Marit G, Caillot D, Mohty M, Lenain P, Hulin C, Facon T, Casassus P, Michallet M, Maisonneuve H, Benboubker L, Maloisel F, Petillon MO, Webb I, Mathiot C, Moreau P. Harousseau JL, et al. Among authors: maloisel f. J Clin Oncol. 2010 Oct 20;28(30):4621-9. doi: 10.1200/JCO.2009.27.9158. Epub 2010 Sep 7. J Clin Oncol. 2010. PMID: 20823406 Clinical Trial.
[Ciprofloxacin-induced thrombopenia].
Santucci R, Bouayad-Agha K, Maloisel F, Couturier F. Santucci R, et al. Among authors: maloisel f. Med Mal Infect. 2012 Apr;42(4):175-6. doi: 10.1016/j.medmal.2012.02.008. Epub 2012 Apr 3. Med Mal Infect. 2012. PMID: 22475418 French. No abstract available.
[Idiosyncratic drug-induced agranulocytosis].
Andrès E, Maloisel F; Groupe d'Etude des Agranulocytoses Médicamenteuses des Hôpitaux Universitaires de Strasbourg. Andrès E, et al. Among authors: maloisel f. Rev Med Interne. 2006 Mar;27(3):209-14. doi: 10.1016/j.revmed.2005.06.008. Epub 2005 Jul 25. Rev Med Interne. 2006. PMID: 16043267 Review. French.
[Idiosyncratic drug-induced agranulocytosis].
Federici L, Weitten T, Alt M, Blaison G, Zamfir A, Audhuy B, Maloisel F, Andrès E. Federici L, et al. Among authors: maloisel f. Presse Med. 2008 Sep;37(9):1327-33. doi: 10.1016/j.lpm.2008.03.013. Epub 2008 Jul 17. Presse Med. 2008. PMID: 18644319 Review. French.
Idiosyncratic drug-induced neutropenia & agranulocytosis.
Andrès E, Mourot-Cottet R, Maloisel F, Séverac F, Keller O, Vogel T, Tebacher M, Weber JC, Kaltenbach G, Gottenberg JE, Goichot B, Sibilia J, Korganow AS, Herbrecht R. Andrès E, et al. Among authors: maloisel f. QJM. 2017 May;110(5):299-305. doi: 10.1093/qjmed/hcw220. Epub 2017 Jan 9. QJM. 2017. PMID: 28069912
Review. Clinical pharmacokinetics of bortezomib.
Levêque D, Carvalho MC, Maloisel F. Levêque D, et al. Among authors: maloisel f. In Vivo. 2007 Mar-Apr;21(2):273-8. In Vivo. 2007. PMID: 17436576 Free article. Review.
Clinical pharmacokinetics of imatinib mesylate.
Levêque D, Maloisel F. Levêque D, et al. Among authors: maloisel f. In Vivo. 2005 Jan-Feb;19(1):77-84. In Vivo. 2005. PMID: 15796158 Free article. Review.
Tuberculosis and atypical mycobacterial infections in ruxolitinib-treated patients with primary or secondary myelofibrosis or polycythemia vera.
Lescuyer S, Ledoux MP, Gravier S, Natarajan-Amé S, Duval C, Maloisel F, Mauvieux L, Toussaint E, Fornecker LM, Herbrecht R. Lescuyer S, et al. Among authors: maloisel f. Int J Infect Dis. 2019 Mar;80:134-136. doi: 10.1016/j.ijid.2019.01.002. Epub 2019 Jan 11. Int J Infect Dis. 2019. PMID: 30639623 Free article.
176 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page